ValorQ4, 24Q1, 25Q2, 25Q3, 25Total de passivos39.55 M39.32 M39.81 M39.06 MCapital total-865 K-5.65 M-9.21 M-13 MTotal de passivos e patrimônio líquido38.68 M33.67 M30.6 M26.06 MDívida total27.29 M———Dívida líquida5.38 M———
Pluri Inc. - Common Stock
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.